Clinical Trial

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

Study acronym: EAST-STROKE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-03-14; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2026-05-14
Trial Details
NCT Number NCT05293080
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Collaborators: University Heart & Vascular Center Hamburg, Department of Cardiology, Department of Neurology, Royal Melbourne Hospital, Melbourne Heart Centre, Royal Melbourne Hospital, Hotchkiss Brain Institute, University of Calgary, Department of Neurology and Neurosurgery, Brain Center, University Medical Center Utrecht, UMC Utrecht, Edinburgh Clinical Trials Unit, Cerebrovascular Research Group, Centre for Clinical Brain Sciences, University of Edinburgh, Department of Cardiovascular Sciences, University of Leicester British Heart Foundation Cardiovascular Research Centre, CTC-NORTH, Stroke Alliance for Europe (SAFE), Kompetenznetz Vorhofflimmern e.V. (AFNET)
Conditions Acute Ischemic Stroke, Atrial Fibrillation
Enrollment 1,746 participants
Start Date 2025-11-06
Primary Completion 2031-07 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-18